• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大普通民众如何看待中度阿尔茨海默病?

How does the canadian general public rate moderate Alzheimer's disease?

作者信息

Tarride Jean-Eric, Oremus Mark, Pullenayegum Eleanor, Clayton Natasha, Raina Parminder

机构信息

Programs for Assessment of Technology in Health (PATH) Research Institute, St. Joseph's Healthcare Hamilton, 25 Main Street West, Suite 2000, Hamilton, ON, Canada L8P 1H1.

出版信息

J Aging Res. 2011;2011:682470. doi: 10.4061/2011/682470. Epub 2011 Dec 20.

DOI:10.4061/2011/682470
PMID:22229093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3250621/
Abstract

Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P < 0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD.

摘要

目的。本研究的目的是利用普通公众得出中度阿尔茨海默病(AD)的健康效用评分。方法。随机选择500名加拿大人参与电话访谈。使用欧洲五维度健康量表(EQ - 5D)来评估受访者当前健康状况(即无AD)以及假设的中度AD健康状态下的健康效用评分。进行回归分析以解释与AD相关的感知效用下降情况。结果。受访者的平均年龄为51岁,60%为女性,42%认识患有AD的人。受访者当前健康状况和假设的中度AD的平均EQ - 5D评分分别为0.873(标准差:0.138)和0.638(标准差:0.194)(P < 0.001)。年龄、性别和教育程度是解释这种效用下降的重要因素。结论。在得出AD患者健康相关生活质量方面,普通公众可作为患者和照料者的替代选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e8/3250621/7b6f6f3467ab/JAR2011-682470.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e8/3250621/915efd31894b/JAR2011-682470.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e8/3250621/7b6f6f3467ab/JAR2011-682470.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e8/3250621/915efd31894b/JAR2011-682470.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e8/3250621/7b6f6f3467ab/JAR2011-682470.002.jpg

相似文献

1
How does the canadian general public rate moderate Alzheimer's disease?加拿大普通民众如何看待中度阿尔茨海默病?
J Aging Res. 2011;2011:682470. doi: 10.4061/2011/682470. Epub 2011 Dec 20.
2
Can the general public use vignettes to discriminate between Alzheimer's disease health states?普通公众能否使用视觉模拟量表来区分阿尔茨海默病的健康状态?
BMC Geriatr. 2016 Feb 3;16:36. doi: 10.1186/s12877-016-0207-4.
3
Measuring health-related quality-of-life for Alzheimer's disease using the general public.使用普通大众衡量阿尔茨海默病相关的生活质量。
Qual Life Res. 2012 May;21(4):593-601. doi: 10.1007/s11136-011-9966-8. Epub 2011 Jul 9.
4
Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.阿尔茨海默病的健康效用评分:基于使用美国和加拿大偏好权重的计算差异。
Value Health. 2014 Jan-Feb;17(1):77-83. doi: 10.1016/j.jval.2013.10.009.
5
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.使用英国和加拿大偏好权重计算的阿尔茨海默病患者及其照料者健康效用得分的比较。
Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y.
6
Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.使用EQ-5D-5L量表测量的健康相关生活质量:南澳大利亚州人群常模。
Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0.
7
[Health-related Quality of Life in Patients with Mild-to-moderate Alzheimer's Disease: A Study Using the Five-level Version of European Quality of Life-5 Dimensions (EQ-5D-5L)].轻度至中度阿尔茨海默病患者的健康相关生活质量:一项使用欧洲生活质量五维度五级量表(EQ-5D-5L)的研究
Brain Nerve. 2019 Jan;71(1):67-73. doi: 10.11477/mf.1416201218.
8
Acceptability and Validity of the EQ-5D in Patients Living With Dementia.痴呆患者的 EQ-5D 的可接受性和有效性。
Value Health. 2020 Jun;23(6):760-767. doi: 10.1016/j.jval.2020.01.022. Epub 2020 May 22.
9
Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems.魁北克健康相关生活质量人群规范使用 EQ-5D-5L:按社会人口学数据和健康问题进行分解。
Value Health. 2020 Feb;23(2):251-259. doi: 10.1016/j.jval.2019.08.008. Epub 2019 Oct 3.
10
Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers.阿尔茨海默病的健康效用:一项针对患者及其照料者的横断面研究
Med Care. 1999 Jan;37(1):27-32. doi: 10.1097/00005650-199901000-00005.

引用本文的文献

1
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.使用英国和加拿大偏好权重计算的阿尔茨海默病患者及其照料者健康效用得分的比较。
Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y.

本文引用的文献

1
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?当某些受试者达到 1 的上限时,健康效用数据的分析:Tobit 和 CLAD 模型是否适用?
Value Health. 2010 Jun-Jul;13(4):487-94. doi: 10.1111/j.1524-4733.2010.00695.x. Epub 2010 Mar 10.
2
Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada.支持增税以提供无限制获取阿尔茨海默病药物的机会:对加拿大公众的调查。
BMC Health Serv Res. 2009 Dec 29;9:246. doi: 10.1186/1472-6963-9-246.
3
Deaths: final data for 2006.
死亡情况:2006年最终数据。
Natl Vital Stat Rep. 2009 Apr 17;57(14):1-134.
4
International price comparisons of Alzheimer's drugs: a way to close the affordability gap.国际间阿尔茨海默病药物价格比较:缩小可负担性差距的一种途径。
Int Psychogeriatr. 2009 Dec;21(6):1116-26. doi: 10.1017/S104161020999086X. Epub 2009 Sep 8.
5
2009 Alzheimer's disease facts and figures.2009年阿尔茨海默病事实与数据。
Alzheimers Dement. 2009 May;5(3):234-70. doi: 10.1016/j.jalz.2009.03.001.
6
The Alzheimer's Disease Knowledge Scale: development and psychometric properties.阿尔茨海默病知识量表:编制与心理测量学特性
Gerontologist. 2009 Apr;49(2):236-47. doi: 10.1093/geront/gnp023. Epub 2009 Mar 25.
7
Factor structure and invariance of the Quality of Life in Alzheimer's Disease (QoL-AD) Scale.阿尔茨海默病生活质量量表(QoL-AD)的因子结构与不变性
Exp Aging Res. 2009 Apr-Jun;35(2):250-67. doi: 10.1080/03610730902720521.
8
Caregivers' assessments of preference-based quality of life in Alzheimer's disease.照顾者对阿尔茨海默病基于偏好的生活质量的评估。
Alzheimers Dement. 2008 May;4(3):203-11. doi: 10.1016/j.jalz.2007.11.018. Epub 2008 Apr 24.
9
Preference-based quality of life in patients with Alzheimer's disease.阿尔茨海默病患者基于偏好的生活质量
Alzheimers Dement. 2008 May;4(3):193-202. doi: 10.1016/j.jalz.2007.11.019. Epub 2008 May 2.
10
Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.患有阿尔茨海默病的医疗保险受益人的医疗保健成本和利用率。
BMC Health Serv Res. 2008 May 22;8:108. doi: 10.1186/1472-6963-8-108.